Global Biosimilar Monoclonal Antibodies Market Insights, Forecast to 2029

Global Biosimilar Monoclonal Antibodies Market Insights, Forecast to 2029

Table of Contents
1 Study Coverage
1.1 Biosimilar Monoclonal Antibodies Product Introduction
1.2 Market by Type
1.2.1 Global Biosimilar Monoclonal Antibodies Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Infliximab
1.2.3 Rituximab
1.2.4 Trastuzumab
1.2.5 Adalimumab
1.2.6 Other
1.3 Market by Application
1.3.1 Global Biosimilar Monoclonal Antibodies Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Oncology
1.3.3 Autoimmune Disease
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Biosimilar Monoclonal Antibodies Sales Estimates and Forecasts 2018-2029
2.2 Global Biosimilar Monoclonal Antibodies Revenue by Region
2.2.1 Global Biosimilar Monoclonal Antibodies Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Biosimilar Monoclonal Antibodies Revenue by Region (2018-2023)
2.2.3 Global Biosimilar Monoclonal Antibodies Revenue by Region (2024-2029)
2.2.4 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region (2018-2029)
2.3 Global Biosimilar Monoclonal Antibodies Sales Estimates and Forecasts 2018-2029
2.4 Global Biosimilar Monoclonal Antibodies Sales by Region
2.4.1 Global Biosimilar Monoclonal Antibodies Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Biosimilar Monoclonal Antibodies Sales by Region (2018-2023)
2.4.3 Global Biosimilar Monoclonal Antibodies Sales by Region (2024-2029)
2.4.4 Global Biosimilar Monoclonal Antibodies Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Biosimilar Monoclonal Antibodies Sales by Manufacturers
3.1.1 Global Biosimilar Monoclonal Antibodies Sales by Manufacturers (2018-2023)
3.1.2 Global Biosimilar Monoclonal Antibodies Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Biosimilar Monoclonal Antibodies in 2022
3.2 Global Biosimilar Monoclonal Antibodies Revenue by Manufacturers
3.2.1 Global Biosimilar Monoclonal Antibodies Revenue by Manufacturers (2018-2023)
3.2.2 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Biosimilar Monoclonal Antibodies Revenue in 2022
3.3 Global Key Players of Biosimilar Monoclonal Antibodies, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Biosimilar Monoclonal Antibodies Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Biosimilar Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Biosimilar Monoclonal Antibodies, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Biosimilar Monoclonal Antibodies, Product Offered and Application
3.8 Global Key Manufacturers of Biosimilar Monoclonal Antibodies, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Biosimilar Monoclonal Antibodies Sales by Type
4.1.1 Global Biosimilar Monoclonal Antibodies Historical Sales by Type (2018-2023)
4.1.2 Global Biosimilar Monoclonal Antibodies Forecasted Sales by Type (2024-2029)
4.1.3 Global Biosimilar Monoclonal Antibodies Sales Market Share by Type (2018-2029)
4.2 Global Biosimilar Monoclonal Antibodies Revenue by Type
4.2.1 Global Biosimilar Monoclonal Antibodies Historical Revenue by Type (2018-2023)
4.2.2 Global Biosimilar Monoclonal Antibodies Forecasted Revenue by Type (2024-2029)
4.2.3 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Type (2018-2029)
4.3 Global Biosimilar Monoclonal Antibodies Price by Type
4.3.1 Global Biosimilar Monoclonal Antibodies Price by Type (2018-2023)
4.3.2 Global Biosimilar Monoclonal Antibodies Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Biosimilar Monoclonal Antibodies Sales by Application
5.1.1 Global Biosimilar Monoclonal Antibodies Historical Sales by Application (2018-2023)
5.1.2 Global Biosimilar Monoclonal Antibodies Forecasted Sales by Application (2024-2029)
5.1.3 Global Biosimilar Monoclonal Antibodies Sales Market Share by Application (2018-2029)
5.2 Global Biosimilar Monoclonal Antibodies Revenue by Application
5.2.1 Global Biosimilar Monoclonal Antibodies Historical Revenue by Application (2018-2023)
5.2.2 Global Biosimilar Monoclonal Antibodies Forecasted Revenue by Application (2024-2029)
5.2.3 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Application (2018-2029)
5.3 Global Biosimilar Monoclonal Antibodies Price by Application
5.3.1 Global Biosimilar Monoclonal Antibodies Price by Application (2018-2023)
5.3.2 Global Biosimilar Monoclonal Antibodies Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Biosimilar Monoclonal Antibodies Market Size by Type
6.1.1 US & Canada Biosimilar Monoclonal Antibodies Sales by Type (2018-2029)
6.1.2 US & Canada Biosimilar Monoclonal Antibodies Revenue by Type (2018-2029)
6.2 US & Canada Biosimilar Monoclonal Antibodies Market Size by Application
6.2.1 US & Canada Biosimilar Monoclonal Antibodies Sales by Application (2018-2029)
6.2.2 US & Canada Biosimilar Monoclonal Antibodies Revenue by Application (2018-2029)
6.3 US & Canada Biosimilar Monoclonal Antibodies Market Size by Country
6.3.1 US & Canada Biosimilar Monoclonal Antibodies Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Biosimilar Monoclonal Antibodies Sales by Country (2018-2029)
6.3.3 US & Canada Biosimilar Monoclonal Antibodies Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Biosimilar Monoclonal Antibodies Market Size by Type
7.1.1 Europe Biosimilar Monoclonal Antibodies Sales by Type (2018-2029)
7.1.2 Europe Biosimilar Monoclonal Antibodies Revenue by Type (2018-2029)
7.2 Europe Biosimilar Monoclonal Antibodies Market Size by Application
7.2.1 Europe Biosimilar Monoclonal Antibodies Sales by Application (2018-2029)
7.2.2 Europe Biosimilar Monoclonal Antibodies Revenue by Application (2018-2029)
7.3 Europe Biosimilar Monoclonal Antibodies Market Size by Country
7.3.1 Europe Biosimilar Monoclonal Antibodies Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Biosimilar Monoclonal Antibodies Sales by Country (2018-2029)
7.3.3 Europe Biosimilar Monoclonal Antibodies Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Biosimilar Monoclonal Antibodies Market Size
8.1.1 China Biosimilar Monoclonal Antibodies Sales (2018-2029)
8.1.2 China Biosimilar Monoclonal Antibodies Revenue (2018-2029)
8.2 China Biosimilar Monoclonal Antibodies Market Size by Application
8.2.1 China Biosimilar Monoclonal Antibodies Sales by Application (2018-2029)
8.2.2 China Biosimilar Monoclonal Antibodies Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Biosimilar Monoclonal Antibodies Market Size by Type
9.1.1 Asia Biosimilar Monoclonal Antibodies Sales by Type (2018-2029)
9.1.2 Asia Biosimilar Monoclonal Antibodies Revenue by Type (2018-2029)
9.2 Asia Biosimilar Monoclonal Antibodies Market Size by Application
9.2.1 Asia Biosimilar Monoclonal Antibodies Sales by Application (2018-2029)
9.2.2 Asia Biosimilar Monoclonal Antibodies Revenue by Application (2018-2029)
9.3 Asia Biosimilar Monoclonal Antibodies Sales by Region
9.3.1 Asia Biosimilar Monoclonal Antibodies Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Biosimilar Monoclonal Antibodies Revenue by Region (2018-2029)
9.3.3 Asia Biosimilar Monoclonal Antibodies Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Biosimilar Monoclonal Antibodies Market Size by Type
10.1.1 Middle East, Africa and Latin America Biosimilar Monoclonal Antibodies Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Biosimilar Monoclonal Antibodies Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Biosimilar Monoclonal Antibodies Market Size by Application
10.2.1 Middle East, Africa and Latin America Biosimilar Monoclonal Antibodies Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Biosimilar Monoclonal Antibodies Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Biosimilar Monoclonal Antibodies Sales by Country
10.3.1 Middle East, Africa and Latin America Biosimilar Monoclonal Antibodies Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Biosimilar Monoclonal Antibodies Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Biosimilar Monoclonal Antibodies Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Celltrion
11.1.1 Celltrion Company Information
11.1.2 Celltrion Overview
11.1.3 Celltrion Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Celltrion Biosimilar Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Celltrion Recent Developments
11.2 Pfizer (Hospira)
11.2.1 Pfizer (Hospira) Company Information
11.2.2 Pfizer (Hospira) Overview
11.2.3 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer (Hospira) Recent Developments
11.3 3SBIO
11.3.1 3SBIO Company Information
11.3.2 3SBIO Overview
11.3.3 3SBIO Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 3SBIO Biosimilar Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 3SBIO Recent Developments
11.4 Novartis (Sandoz)
11.4.1 Novartis (Sandoz) Company Information
11.4.2 Novartis (Sandoz) Overview
11.4.3 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novartis (Sandoz) Recent Developments
11.5 Dr Reddy's
11.5.1 Dr Reddy's Company Information
11.5.2 Dr Reddy's Overview
11.5.3 Dr Reddy's Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Dr Reddy's Biosimilar Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Dr Reddy's Recent Developments
11.6 Celgen Biopharma
11.6.1 Celgen Biopharma Company Information
11.6.2 Celgen Biopharma Overview
11.6.3 Celgen Biopharma Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Celgen Biopharma Biosimilar Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Celgen Biopharma Recent Developments
11.7 Cadila Healthcare
11.7.1 Cadila Healthcare Company Information
11.7.2 Cadila Healthcare Overview
11.7.3 Cadila Healthcare Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Cadila Healthcare Biosimilar Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Cadila Healthcare Recent Developments
11.8 Hisun Pharma
11.8.1 Hisun Pharma Company Information
11.8.2 Hisun Pharma Overview
11.8.3 Hisun Pharma Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Hisun Pharma Biosimilar Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Hisun Pharma Recent Developments
11.9 Torrent Pharmaceuticals
11.9.1 Torrent Pharmaceuticals Company Information
11.9.2 Torrent Pharmaceuticals Overview
11.9.3 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Torrent Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Biosimilar Monoclonal Antibodies Industry Chain Analysis
12.2 Biosimilar Monoclonal Antibodies Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Biosimilar Monoclonal Antibodies Production Mode & Process
12.4 Biosimilar Monoclonal Antibodies Sales and Marketing
12.4.1 Biosimilar Monoclonal Antibodies Sales Channels
12.4.2 Biosimilar Monoclonal Antibodies Distributors
12.5 Biosimilar Monoclonal Antibodies Customers
13 Market Dynamics
13.1 Biosimilar Monoclonal Antibodies Industry Trends
13.2 Biosimilar Monoclonal Antibodies Market Drivers
13.3 Biosimilar Monoclonal Antibodies Market Challenges
13.4 Biosimilar Monoclonal Antibodies Market Restraints
14 Key Findings in The Global Biosimilar Monoclonal Antibodies Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Biosimilar Monoclonal Antibodies Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Infliximab
Table 3. Major Manufacturers of Rituximab
Table 4. Major Manufacturers of Trastuzumab
Table 5. Major Manufacturers of Adalimumab
Table 6. Major Manufacturers of Other
Table 7. Global Biosimilar Monoclonal Antibodies Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Biosimilar Monoclonal Antibodies Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. Global Biosimilar Monoclonal Antibodies Revenue by Region (2018-2023) & (US$ Million)
Table 10. Global Biosimilar Monoclonal Antibodies Revenue by Region (2024-2029) & (US$ Million)
Table 11. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region (2018-2023)
Table 12. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region (2024-2029)
Table 13. Global Biosimilar Monoclonal Antibodies Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 14. Global Biosimilar Monoclonal Antibodies Sales by Region (2018-2023) & (K Units)
Table 15. Global Biosimilar Monoclonal Antibodies Sales by Region (2024-2029) & (K Units)
Table 16. Global Biosimilar Monoclonal Antibodies Sales Market Share by Region (2018-2023)
Table 17. Global Biosimilar Monoclonal Antibodies Sales Market Share by Region (2024-2029)
Table 18. Global Biosimilar Monoclonal Antibodies Sales by Manufacturers (2018-2023) & (K Units)
Table 19. Global Biosimilar Monoclonal Antibodies Sales Share by Manufacturers (2018-2023)
Table 20. Global Biosimilar Monoclonal Antibodies Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 21. Global Biosimilar Monoclonal Antibodies Revenue Share by Manufacturers (2018-2023)
Table 22. Global Key Players of Biosimilar Monoclonal Antibodies, Industry Ranking, 2021 VS 2022 VS 2023
Table 23. Biosimilar Monoclonal Antibodies Price by Manufacturers 2018-2023 (USD/Unit)
Table 24. Global Biosimilar Monoclonal Antibodies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Biosimilar Monoclonal Antibodies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Monoclonal Antibodies as of 2022)
Table 26. Global Key Manufacturers of Biosimilar Monoclonal Antibodies, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Biosimilar Monoclonal Antibodies, Product Offered and Application
Table 28. Global Key Manufacturers of Biosimilar Monoclonal Antibodies, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Biosimilar Monoclonal Antibodies Sales by Type (2018-2023) & (K Units)
Table 31. Global Biosimilar Monoclonal Antibodies Sales by Type (2024-2029) & (K Units)
Table 32. Global Biosimilar Monoclonal Antibodies Sales Share by Type (2018-2023)
Table 33. Global Biosimilar Monoclonal Antibodies Sales Share by Type (2024-2029)
Table 34. Global Biosimilar Monoclonal Antibodies Revenue by Type (2018-2023) & (US$ Million)
Table 35. Global Biosimilar Monoclonal Antibodies Revenue by Type (2024-2029) & (US$ Million)
Table 36. Global Biosimilar Monoclonal Antibodies Revenue Share by Type (2018-2023)
Table 37. Global Biosimilar Monoclonal Antibodies Revenue Share by Type (2024-2029)
Table 38. Biosimilar Monoclonal Antibodies Price by Type (2018-2023) & (USD/Unit)
Table 39. Global Biosimilar Monoclonal Antibodies Price Forecast by Type (2024-2029) & (USD/Unit)
Table 40. Global Biosimilar Monoclonal Antibodies Sales by Application (2018-2023) & (K Units)
Table 41. Global Biosimilar Monoclonal Antibodies Sales by Application (2024-2029) & (K Units)
Table 42. Global Biosimilar Monoclonal Antibodies Sales Share by Application (2018-2023)
Table 43. Global Biosimilar Monoclonal Antibodies Sales Share by Application (2024-2029)
Table 44. Global Biosimilar Monoclonal Antibodies Revenue by Application (2018-2023) & (US$ Million)
Table 45. Global Biosimilar Monoclonal Antibodies Revenue by Application (2024-2029) & (US$ Million)
Table 46. Global Biosimilar Monoclonal Antibodies Revenue Share by Application (2018-2023)
Table 47. Global Biosimilar Monoclonal Antibodies Revenue Share by Application (2024-2029)
Table 48. Biosimilar Monoclonal Antibodies Price by Application (2018-2023) & (USD/Unit)
Table 49. Global Biosimilar Monoclonal Antibodies Price Forecast by Application (2024-2029) & (USD/Unit)
Table 50. US & Canada Biosimilar Monoclonal Antibodies Sales by Type (2018-2023) & (K Units)
Table 51. US & Canada Biosimilar Monoclonal Antibodies Sales by Type (2024-2029) & (K Units)
Table 52. US & Canada Biosimilar Monoclonal Antibodies Revenue by Type (2018-2023) & (US$ Million)
Table 53. US & Canada Biosimilar Monoclonal Antibodies Revenue by Type (2024-2029) & (US$ Million)
Table 54. US & Canada Biosimilar Monoclonal Antibodies Sales by Application (2018-2023) & (K Units)
Table 55. US & Canada Biosimilar Monoclonal Antibodies Sales by Application (2024-2029) & (K Units)
Table 56. US & Canada Biosimilar Monoclonal Antibodies Revenue by Application (2018-2023) & (US$ Million)
Table 57. US & Canada Biosimilar Monoclonal Antibodies Revenue by Application (2024-2029) & (US$ Million)
Table 58. US & Canada Biosimilar Monoclonal Antibodies Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 59. US & Canada Biosimilar Monoclonal Antibodies Revenue by Country (2018-2023) & (US$ Million)
Table 60. US & Canada Biosimilar Monoclonal Antibodies Revenue by Country (2024-2029) & (US$ Million)
Table 61. US & Canada Biosimilar Monoclonal Antibodies Sales by Country (2018-2023) & (K Units)
Table 62. US & Canada Biosimilar Monoclonal Antibodies Sales by Country (2024-2029) & (K Units)
Table 63. Europe Biosimilar Monoclonal Antibodies Sales by Type (2018-2023) & (K Units)
Table 64. Europe Biosimilar Monoclonal Antibodies Sales by Type (2024-2029) & (K Units)
Table 65. Europe Biosimilar Monoclonal Antibodies Revenue by Type (2018-2023) & (US$ Million)
Table 66. Europe Biosimilar Monoclonal Antibodies Revenue by Type (2024-2029) & (US$ Million)
Table 67. Europe Biosimilar Monoclonal Antibodies Sales by Application (2018-2023) & (K Units)
Table 68. Europe Biosimilar Monoclonal Antibodies Sales by Application (2024-2029) & (K Units)
Table 69. Europe Biosimilar Monoclonal Antibodies Revenue by Application (2018-2023) & (US$ Million)
Table 70. Europe Biosimilar Monoclonal Antibodies Revenue by Application (2024-2029) & (US$ Million)
Table 71. Europe Biosimilar Monoclonal Antibodies Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 72. Europe Biosimilar Monoclonal Antibodies Revenue by Country (2018-2023) & (US$ Million)
Table 73. Europe Biosimilar Monoclonal Antibodies Revenue by Country (2024-2029) & (US$ Million)
Table 74. Europe Biosimilar Monoclonal Antibodies Sales by Country (2018-2023) & (K Units)
Table 75. Europe Biosimilar Monoclonal Antibodies Sales by Country (2024-2029) & (K Units)
Table 76. China Biosimilar Monoclonal Antibodies Sales by Type (2018-2023) & (K Units)
Table 77. China Biosimilar Monoclonal Antibodies Sales by Type (2024-2029) & (K Units)
Table 78. China Biosimilar Monoclonal Antibodies Revenue by Type (2018-2023) & (US$ Million)
Table 79. China Biosimilar Monoclonal Antibodies Revenue by Type (2024-2029) & (US$ Million)
Table 80. China Biosimilar Monoclonal Antibodies Sales by Application (2018-2023) & (K Units)
Table 81. China Biosimilar Monoclonal Antibodies Sales by Application (2024-2029) & (K Units)
Table 82. China Biosimilar Monoclonal Antibodies Revenue by Application (2018-2023) & (US$ Million)
Table 83. China Biosimilar Monoclonal Antibodies Revenue by Application (2024-2029) & (US$ Million)
Table 84. Asia Biosimilar Monoclonal Antibodies Sales by Type (2018-2023) & (K Units)
Table 85. Asia Biosimilar Monoclonal Antibodies Sales by Type (2024-2029) & (K Units)
Table 86. Asia Biosimilar Monoclonal Antibodies Revenue by Type (2018-2023) & (US$ Million)
Table 87. Asia Biosimilar Monoclonal Antibodies Revenue by Type (2024-2029) & (US$ Million)
Table 88. Asia Biosimilar Monoclonal Antibodies Sales by Application (2018-2023) & (K Units)
Table 89. Asia Biosimilar Monoclonal Antibodies Sales by Application (2024-2029) & (K Units)
Table 90. Asia Biosimilar Monoclonal Antibodies Revenue by Application (2018-2023) & (US$ Million)
Table 91. Asia Biosimilar Monoclonal Antibodies Revenue by Application (2024-2029) & (US$ Million)
Table 92. Asia Biosimilar Monoclonal Antibodies Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 93. Asia Biosimilar Monoclonal Antibodies Revenue by Region (2018-2023) & (US$ Million)
Table 94. Asia Biosimilar Monoclonal Antibodies Revenue by Region (2024-2029) & (US$ Million)
Table 95. Asia Biosimilar Monoclonal Antibodies Sales by Region (2018-2023) & (K Units)
Table 96. Asia Biosimilar Monoclonal Antibodies Sales by Region (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Biosimilar Monoclonal Antibodies Sales by Type (2018-2023) & (K Units)
Table 98. Middle East, Africa and Latin America Biosimilar Monoclonal Antibodies Sales by Type (2024-2029) & (K Units)
Table 99. Middle East, Africa and Latin America Biosimilar Monoclonal Antibodies Revenue by Type (2018-2023) & (US$ Million)
Table 100. Middle East, Africa and Latin America Biosimilar Monoclonal Antibodies Revenue by Type (2024-2029) & (US$ Million)
Table 101. Middle East, Africa and Latin America Biosimilar Monoclonal Antibodies Sales by Application (2018-2023) & (K Units)
Table 102. Middle East, Africa and Latin America Biosimilar Monoclonal Antibodies Sales by Application (2024-2029) & (K Units)
Table 103. Middle East, Africa and Latin America Biosimilar Monoclonal Antibodies Revenue by Application (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Biosimilar Monoclonal Antibodies Revenue by Application (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Biosimilar Monoclonal Antibodies Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Middle East, Africa and Latin America Biosimilar Monoclonal Antibodies Revenue by Country (2018-2023) & (US$ Million)
Table 107. Middle East, Africa and Latin America Biosimilar Monoclonal Antibodies Revenue by Country (2024-2029) & (US$ Million)
Table 108. Middle East, Africa and Latin America Biosimilar Monoclonal Antibodies Sales by Country (2018-2023) & (K Units)
Table 109. Middle East, Africa and Latin America Biosimilar Monoclonal Antibodies Sales by Country (2024-2029) & (K Units)
Table 110. Celltrion Company Information
Table 111. Celltrion Description and Major Businesses
Table 112. Celltrion Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Celltrion Biosimilar Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Celltrion Recent Developments
Table 115. Pfizer (Hospira) Company Information
Table 116. Pfizer (Hospira) Description and Major Businesses
Table 117. Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Pfizer (Hospira) Biosimilar Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Pfizer (Hospira) Recent Developments
Table 120. 3SBIO Company Information
Table 121. 3SBIO Description and Major Businesses
Table 122. 3SBIO Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. 3SBIO Biosimilar Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. 3SBIO Recent Developments
Table 125. Novartis (Sandoz) Company Information
Table 126. Novartis (Sandoz) Description and Major Businesses
Table 127. Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. Novartis (Sandoz) Biosimilar Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Novartis (Sandoz) Recent Developments
Table 130. Dr Reddy's Company Information
Table 131. Dr Reddy's Description and Major Businesses
Table 132. Dr Reddy's Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. Dr Reddy's Biosimilar Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Dr Reddy's Recent Developments
Table 135. Celgen Biopharma Company Information
Table 136. Celgen Biopharma Description and Major Businesses
Table 137. Celgen Biopharma Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. Celgen Biopharma Biosimilar Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Celgen Biopharma Recent Developments
Table 140. Cadila Healthcare Company Information
Table 141. Cadila Healthcare Description and Major Businesses
Table 142. Cadila Healthcare Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 143. Cadila Healthcare Biosimilar Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Cadila Healthcare Recent Developments
Table 145. Hisun Pharma Company Information
Table 146. Hisun Pharma Description and Major Businesses
Table 147. Hisun Pharma Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 148. Hisun Pharma Biosimilar Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Hisun Pharma Recent Developments
Table 150. Torrent Pharmaceuticals Company Information
Table 151. Torrent Pharmaceuticals Description and Major Businesses
Table 152. Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 153. Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Torrent Pharmaceuticals Recent Developments
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Biosimilar Monoclonal Antibodies Distributors List
Table 158. Biosimilar Monoclonal Antibodies Customers List
Table 159. Biosimilar Monoclonal Antibodies Market Trends
Table 160. Biosimilar Monoclonal Antibodies Market Drivers
Table 161. Biosimilar Monoclonal Antibodies Market Challenges
Table 162. Biosimilar Monoclonal Antibodies Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Biosimilar Monoclonal Antibodies Product Picture
Figure 2. Global Biosimilar Monoclonal Antibodies Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Biosimilar Monoclonal Antibodies Market Share by Type in 2022 & 2029
Figure 4. Infliximab Product Picture
Figure 5. Rituximab Product Picture
Figure 6. Trastuzumab Product Picture
Figure 7. Adalimumab Product Picture
Figure 8. Other Product Picture
Figure 9. Global Biosimilar Monoclonal Antibodies Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 10. Global Biosimilar Monoclonal Antibodies Market Share by Application in 2022 & 2029
Figure 11. Oncology
Figure 12. Autoimmune Disease
Figure 13. Other
Figure 14. Biosimilar Monoclonal Antibodies Report Years Considered
Figure 15. Global Biosimilar Monoclonal Antibodies Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Biosimilar Monoclonal Antibodies Revenue 2018-2029 (US$ Million)
Figure 17. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 18. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region (2018-2029)
Figure 19. Global Biosimilar Monoclonal Antibodies Sales 2018-2029 ((K Units)
Figure 20. Global Biosimilar Monoclonal Antibodies Sales Market Share by Region (2018-2029)
Figure 21. US & Canada Biosimilar Monoclonal Antibodies Sales YoY (2018-2029) & (K Units)
Figure 22. US & Canada Biosimilar Monoclonal Antibodies Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Europe Biosimilar Monoclonal Antibodies Sales YoY (2018-2029) & (K Units)
Figure 24. Europe Biosimilar Monoclonal Antibodies Revenue YoY (2018-2029) & (US$ Million)
Figure 25. China Biosimilar Monoclonal Antibodies Sales YoY (2018-2029) & (K Units)
Figure 26. China Biosimilar Monoclonal Antibodies Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Asia (excluding China) Biosimilar Monoclonal Antibodi

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 147

According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......

Global Biosimilar Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94

According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......

Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 147

According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period. Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......

Global Biosimilars Market Research Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 167

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 133

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Biosimilars market: According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years. A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......

Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 3280 Onwards        Pages: 134

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 2680 Onwards        Pages: 160

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Biosimilar Monoclonal Antibodies market: According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs